Wells Fargo raised the firm’s price target on Amrize (AMRZ) to $59 from $58 and keeps an Overweight rating on the shares. The firm remains selective in its building mats recommendations, preferring early-cycle exposure as Wells anticipates some housing/remodeling recovery.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMRZ:
- Amrize Sets February Date for Fourth-Quarter and Full-Year 2025 Results
- Amrize price target raised to $64 from $62 at Oppenheimer
- Amrize price target raised to $67 from $63 at Citi
- Amrize to Buy West Texas Aggregates Leader PB Materials in Growth Push
- Amrize to acquire PB Materials, terms not disclosed